Company intelligence
IXICO
Precision in neuroscience
Biotechnology Research
London, GB
95 employees
Founded 2004
3 public signals
About IXICO
IXICO is no ordinary Imaging Contract Research Organisation (iCRO). By unlocking valuable insights into drug safety and efficacy, IXICO has built a highly respected global reputation and a 20-year track record as an end-to-end iCRO. IXICO addresses the complex biomarker challenges associated with neurodegenerative conditions, expertly managing and analysing neuroimaging clinical trials in areas such as Alzheimer’s, Parkinson’s, Huntington's and other rare diseases.
Verified activity
Signals from IXICO
3 published signals
Presence & Recognition
IXICO hosted its Summer Party on Friday to celebrate achievements and welcome new team members.
Reported by IXICO
Presence & Recognition
IXICO is exhibiting at Booth 216 in Seoul at MDS Congress 2026 to support the development of new therapies for Parkinson's disease and parkinsonian disorders.
Reported by IXICO
Research & Knowledge
IXICO published a blog post discussing research exploring the association between white matter hyperintensities and cognitive decline by Mihyun Waugh, Senior Biomarker Scientist and Alzheimer's expert.
Reported by IXICO